• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of Alcohol Relapse Following Liver Transplantation for Alcohol-Induced Liver Failure. Consideration of "A-D" Selection Criteria.酒精性肝衰竭肝移植后酒精复饮的预测因素。对“A-D”选择标准的考量。
Ann Transplant. 2018 Feb 20;23:129-135. doi: 10.12659/AOT.905646.
2
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
3
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).纳武单抗用于成人霍奇金淋巴瘤(使用RobotReviewer软件进行的快速综述)
Cochrane Database Syst Rev. 2018 Jul 12;7(7):CD012556. doi: 10.1002/14651858.CD012556.pub2.
4
Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.用于治疗同时患有抑郁症和酒精依赖症患者的抗抑郁药。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008581. doi: 10.1002/14651858.CD008581.pub2.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
A systematic overview of chemotherapy effects in acute myeloid leukaemia.急性髓系白血病化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):231-52. doi: 10.1080/02841860151116321.
7
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
8
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Effectiveness of brief alcohol interventions in primary care populations.简短酒精干预措施在初级保健人群中的有效性。
Cochrane Database Syst Rev. 2018 Feb 24;2(2):CD004148. doi: 10.1002/14651858.CD004148.pub4.

引用本文的文献

1
Liver Transplantation in Alcohol-Associated Liver Disease.酒精性肝病的肝移植
Clin Liver Dis. 2025 May;29(2):165-184. doi: 10.1016/j.cld.2024.12.001. Epub 2025 Jan 30.
2
Factors Associated with Relapses in Alcohol and Substance Use Disorder.酒精及物质使用障碍复发的相关因素
Eurasian J Med. 2023 Dec;55(1):S75-S81. doi: 10.5152/eurasianjmed.2023.23335.
3
A Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients Is Feasible and Associated With Lower Post-Transplant Relapse.为肝移植候选者和接受者量身定制的酒精使用障碍治疗虚拟项目是可行的,且与移植后较低的复发率相关。
Clin Transplant. 2024 Jul;38(7):e15381. doi: 10.1111/ctr.15381.
4
Effect of a multidisciplinary approach on hospital visit continuation in the treatment of patients with alcohol dependence.多学科方法对酒精依赖患者治疗中住院治疗延续的影响。
Neuropsychopharmacol Rep. 2023 Dec;43(4):542-552. doi: 10.1002/npr2.12349. Epub 2023 May 22.
5
New Treatment Models for Alcohol Use Disorders and Alcoholic Liver Disease.酒精使用障碍和酒精性肝病的新治疗模式
Clin Liver Dis (Hoboken). 2019 May 31;13(5):118-122. doi: 10.1002/cld.804. eCollection 2019 May.

本文引用的文献

1
Assessing and treating alcohol relapse risk in liver transplantation candidates.评估和治疗肝移植候选者的酒精复饮风险。
Alcohol Alcohol. 2015 Mar;50(2):164-72. doi: 10.1093/alcalc/agu096. Epub 2015 Jan 3.
2
Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.成人肝移植评估:美国肝病研究协会和美国移植学会2013年实践指南
Hepatology. 2014 Mar;59(3):1144-65. doi: 10.1002/hep.26972.
3
Risk factors for alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan.日本酒精性肝硬化肝移植术后酒精复饮的危险因素。
Liver Transpl. 2014 Mar;20(3):298-310. doi: 10.1002/lt.23797. Epub 2014 Jan 27.
4
The Alcohol Relapse Risk Assessment: a scoring system to predict the risk of relapse to any alcohol use after liver transplant.酒精复发风险评估:一种预测肝移植后再次饮酒风险的评分系统。
Prog Transplant. 2013 Dec;23(4):310-8. doi: 10.7182/pit2013604.
5
Liver transplantation for alcoholic liver disease among Canadian transplant centres: a national study.加拿大移植中心中酒精性肝病的肝移植:一项全国性研究。
Can J Gastroenterol. 2013 Nov;27(11):643-6. doi: 10.1155/2013/897467. Epub 2013 Sep 13.
6
Strong predictors for alcohol recidivism after liver transplantation: non-acceptance of the alcohol problem and abstinence of <3 months.肝移植后酒精复饮的强烈预测因素:不承认存在酒精问题以及戒酒时间不足3个月。
Scand J Gastroenterol. 2011 Oct;46(10):1257-66. doi: 10.3109/00365521.2011.603160. Epub 2011 Aug 5.
7
Current status and future of liver transplantation.肝脏移植的现状与未来。
Semin Liver Dis. 2010 Nov;30(4):411-21. doi: 10.1055/s-0030-1267541. Epub 2010 Oct 19.
8
Predictors of relapse to significant alcohol drinking after liver transplantation.肝移植后大量饮酒复发的预测因素。
Can J Gastroenterol. 2010 Apr;24(4):245-50. doi: 10.1155/2010/596246.
9
A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation.移植前戒酒时间较短预示着肝移植后存在饮酒问题。
Am J Gastroenterol. 2009 Jul;104(7):1700-6. doi: 10.1038/ajg.2009.226. Epub 2009 May 26.
10
Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease.酒精性肝病肝移植后酒精和非法药物复吸的预测因素。
Transplantation. 2008 Oct 27;86(8):1090-5. doi: 10.1097/TP.0b013e3181872710.

酒精性肝衰竭肝移植后酒精复饮的预测因素。对“A-D”选择标准的考量。

Predictors of Alcohol Relapse Following Liver Transplantation for Alcohol-Induced Liver Failure. Consideration of "A-D" Selection Criteria.

作者信息

Gong Annie, Minuk Gerald Y

机构信息

Section of Hepatology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada.

出版信息

Ann Transplant. 2018 Feb 20;23:129-135. doi: 10.12659/AOT.905646.

DOI:10.12659/AOT.905646
PMID:29459581
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6248322/
Abstract

Demonstrated abstinence from alcohol for over six months and successful completion of a formal alcohol addictions program are two commonly employed criteria for determining whether an alcoholic patient with liver failure should proceed to liver transplantation. In this systematic review of the medical literature, we review the justification for these criteria and consider other variables that have also been reported to be of predictive value. While abstinence from alcohol for over six months is supported by the medical literature, data are more limited regarding the value of formal alcohol addictions program as selection criteria for proceeding towards liver transplantation. Positive family histories of alcoholism, co-inhabitants drinking alcohol in the presence of the patient and concurrent drug dependencies are more robust predictor variables of post-transplant recidivism. Based on the findings of this review, we propose a simple A-D transplantation selection criteria wherein "A" refers to demonstrated abstention from alcohol for over six months, "B" biology (a negative family history for alcoholism), "C", co-inhabitants not consuming alcohol in the presence of the patient; and "D", no concurrent drug dependency.

摘要

证明戒酒超过六个月且成功完成正规戒酒计划是确定患有肝衰竭的酗酒患者是否应进行肝移植的两个常用标准。在对医学文献的这项系统综述中,我们审视了这些标准的依据,并考虑了其他据报道也具有预测价值的变量。虽然医学文献支持戒酒超过六个月,但关于正规戒酒计划作为肝移植选择标准的价值的数据更为有限。酗酒的阳性家族史、患者在场时共同居住者饮酒以及并发药物依赖是移植后复发更强有力的预测变量。基于本综述的结果,我们提出一个简单的A - D移植选择标准,其中“A”指证明戒酒超过六个月,“B”指生物学因素(酗酒家族史阴性),“C”指患者在场时共同居住者不饮酒;“D”指无并发药物依赖。